Ishikawa H, Yoshitomi T, Mashimo K, Nakanishi M, Shimizu K (February 2002). “Pharmacological effects of latanoprost, prostaglandin E2, and F2alpha on isolated rabbit ciliary artery”. Graefes Arch. Clin. Exp. Ophthalmol.240 (2): 120–5. doi:10.1007/s00417-001-0412-4. PMID11931077.
Patel SS, Spencer CM (1996). “Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension”. Drugs Aging9 (5): 363–378. doi:10.2165/00002512-199609050-00007. PMID8922563.
Aung T; Wong HT; Yip CC; et al. (2000). “Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.”. Ophthalmology107 (6): 1178–83. doi:10.1016/s0161-6420(00)00073-7. PMID10857840.
Amano S, Nakai Y, Ko A, Inoue K, Wakakura M (2008). “A case of keratoconus progression associated with the use of topical latanoprost”. Japanese Journal of Ophthalmology52 (4): 334–6. doi:10.1007/s10384-008-0554-6. PMID18773275.
nih.gov
pubmed.ncbi.nlm.nih.gov
Ishikawa H, Yoshitomi T, Mashimo K, Nakanishi M, Shimizu K (February 2002). “Pharmacological effects of latanoprost, prostaglandin E2, and F2alpha on isolated rabbit ciliary artery”. Graefes Arch. Clin. Exp. Ophthalmol.240 (2): 120–5. doi:10.1007/s00417-001-0412-4. PMID11931077.
Patel SS, Spencer CM (1996). “Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension”. Drugs Aging9 (5): 363–378. doi:10.2165/00002512-199609050-00007. PMID8922563.
Aung T; Wong HT; Yip CC; et al. (2000). “Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.”. Ophthalmology107 (6): 1178–83. doi:10.1016/s0161-6420(00)00073-7. PMID10857840.
Amano S, Nakai Y, Ko A, Inoue K, Wakakura M (2008). “A case of keratoconus progression associated with the use of topical latanoprost”. Japanese Journal of Ophthalmology52 (4): 334–6. doi:10.1007/s10384-008-0554-6. PMID18773275.